Finance

Lists
Why is BNGO down ८.०१%?
Dive Deeper
BNGO:NASDAQ
BioNano Genomics Inc
US$ १.३२
-८.०१%
(-०.११) 1D
अक्टोबर १२, ११:५८:२१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNGO...
Open
US$ १.४१
High
US$ १.४२
Low
US$ १.३१
Mkt. cap
१.५५ करोड
Avg. vol.
१८.२५ लाख
Volume
१.५९ लाख
52-wk high
US$ २.२३
52-wk low
US$ १.००
EPS
-US$ ३.७६
Beta
१.६६
Shares outstanding
१.१८ करोड
No. of employees
९६
Open
US$ १.४१
High
US$ १.४२
Low
US$ १.३१
Mkt. cap
१.५५ करोड
Avg. vol.
१८.२५ लाख
Volume
१.५९ लाख
52-wk high
US$ २.२३
52-wk low
US$ १.००
EPS
-US$ ३.७६
Beta
१.६६
Shares outstanding
१.१८ करोड
No. of employees
९६
News stories
From web sources and news partners
The Malaysian Reserve
The Malaysian Reserve
·
२६ मिनेट पहिले
SSA Commissioner Headlines Columbus Day at the NYSE: NYSE Content Update
The Detroit News
The Detroit News
·
२७ मिनेट पहिले
Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
Yahoo Finance
Yahoo Finance
·
२ घण्टा पहिले
A handful of tech stocks are masking an ugly S&P 500 problem
About BioNano Genomics Inc
CEOErik Holmlin
Employees९६
Founded२००३
Headquartersसान डिएगो, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to BNGO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BNGO in the last 3 months
Highest
Current US$ १.३२
US$ ४.०० (+२०३.०३%)
Average
US$ ४.०० (+२०३.०३%)
Lowest
US$ ४.०० (+२०३.०३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ४.००
+२०३%
09/10/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$ ६.००
+३५४.५%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
७३.६७ लाख
७९.५१ लाख
६६.८७ लाख
८१.७१ लाख
Cost of goods sold
३९.९७ लाख
४५.५२ लाख
३४.३५ लाख
३८.५७ लाख
Cost of revenue
३९.९७ लाख
४५.५२ लाख
३४.३५ लाख
३८.५७ लाख
Research and development expenses
२८.४४ लाख
३२.२९ लाख
३१.३९ लाख
२९.८८ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
९०.६४ लाख
८७.०६ लाख
८०.१० लाख
८५.४४ लाख
Operating expense
१.१९ करोड
१.१९ करोड
१.११ करोड
१.१५ करोड
Total operating expenses
१.५९ करोड
१.६५ करोड
१.४६ करोड
१.५४ करोड
Operating income
-८५.३८ लाख
-८५.३६ लाख
-७८.९७ लाख
-७२.१८ लाख
Other non operating income
-१.५० लाख
४.३४ लाख
-५.४७ लाख
-२.७४ लाख
EBT including unusual items
-८४.८९ लाख
-७८.९८ लाख
-८२.९३ लाख
-७४.१६ लाख
EBT excluding unusual items
-८४.८९ लाख
-७८.९८ लाख
-८२.९३ लाख
-७४.१६ लाख
Income tax expense
१४.०० हजार
३५.०० हजार
१०.०० हजार
७.०० हजार
Effective tax rate
-०.१६%
-०.४४%
-०.१२%
-०.०९%
Other operating expenses
-
-
-
-
Net income
-८५.०३ लाख
-७९.३३ लाख
-८३.०३ लाख
-७४.२३ लाख
Net profit margin
-११५.४२%
-९९.७७%
-१२४.१७%
-९०.८५%
Earnings per share
-१.५९
-०.०३
-०.७५
-०.६०
Interest and investment income
२.६८ लाख
२.७६ लाख
२.२३ लाख
१.४६ लाख
Interest expense
-६९.०० हजार
-७२.०० हजार
-७२.०० हजार
-७०.०० हजार
Net interest expenses
१.९९ लाख
२.०४ लाख
१.५१ लाख
७६.०० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-६१.११ लाख
-६१.४८ लाख
-५५.३६ लाख
-४८.७१ लाख
Gain or loss from assets sale
-
-
३४.०० हजार
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू